KetoSwiss

KetoSwiss develops & markets high quality exogenous ketone body therapeutics for use in disease prevention and treatment of specifically neurological diseases.

[Dr Elena Gross, Ph.D. | Migraine Expert @DrElenaGross]

After many years of R&D, MigraKet is finally launching in the US today! Addressing a potential root cause rather than migraine symptoms, MigraKet is designed to improve brain energy metabolism,with bioactive ketone bodies & 30 other crucial micronutrients: https://t.co/aGg2JTQKZB

[startupticker @startuptickerCH]

Biotech @KetoSwiss launches #MigraKet, the first medical food for migraine in the U.S.
https://t.co/bQ5gu6u6qb

[Dr Elena Gross, Ph.D. | Migraine Expert @DrElenaGross]

Reminiscing about the great @ihs_official (#IHC2023) in Seoul, where our research on migraine and metabolism got featured in a main presentation, I finally met the founder of @MigraineSummit & powerful migraine researcher ladies as well as other great migraine experts.

[Longevity Technology @LongevityTech]

KetoSwiss raises $4.8m to boost #brainenergetics via therapeutic ketosis.
@KetoSwiss has announced the 2nd closing of its pre-series A round, led by The William K Warren Foundation.
#investment #funding #longevity
https://t.co/Q6pDgs5L7s

[Swiss Business Hub @SBH_Germany]

@KetoSwiss sammelte 4 Mio. $ in einer Frühfinanzierung ein. Das #Startup aus #Basel erforscht den #Stoffwechsel im Gehirn und die Rolle von Ketonen. MigraKet von @brainritual, dem ersten medizinischen Produkt von KetoSwiss, bekämpft Migräne.

https://t.co/qU9pppwY8q

[Metabolic Health Summit @MetabolicSummit]

More than one billion individuals around the world suffer from migraines each year. Despite being one of the most common neurological disorders on the planet, many troubled by migraines continue to suffer. Lack of efficacious treatment options is exactly what led our most recent interview guest of The Metabolic Link, @DrElenaGross to better understand this common disease and its underlying link to metabolism. Watch the full episode here: https://t.co/oLQyGderDB

[Scientific Reports @SciReports]

Research by @DrElenaGross @AdrianSotoMota and colleagues provides further evidence for a “metabolic migraine” subgroup of patients and identified accessible biomarkers to aid treatments and prophylactic interventions
https://t.co/nlSw9BeS7z

[Dr Elena Gross, Ph.D. | Migraine Expert @DrElenaGross]

@Vitafoods_ Day 2 for the @KetoSwiss / @brainritual team 🎉💚 #vitafoodseurope #vitafoods #vitafoods2023

[EMHA- European Migraine and Headache Alliance @EMHAlliance]

Thank you @KetoSwiss for joining the Migraine Friendly Workplace community!

EMHA recognizes KetoSwiss for the work done in raising awareness on Migraine and improving the health of its employees through opportunities and initiatives at the workplace.

[KetoSwiss @KetoSwiss]

With the end of 2022 nearing we wanted to take this time to thank everyone who has been supporting us in our mission to help migraineurs and bring awareness to the metabolic aspect of neurological and psychiatric diseases. Have a wonderful Holiday Season and a happy New Year!

[Triin Linamagi @triinlinamagi]

Huge congrats to Sie’s Cohort II company @DrElenaGross @KetoSwiss on raising $4M to expand to the US and invest in R&D to treat migraines. So proud of you!

[KetoSwiss @KetoSwiss]

We were honoured to talk to Business Insider about our recent pre-series A raise, milestones still to come and the upcoming launch of #MigraKet in the US! Thanks for sharing our story ✨ @brainritual @DrElenaGross

https://t.co/bBICuwX8bf

[Venturelab @venturelab_ch]

Today's startup funding news: @Carvolution_AG secures CHF16.2M, @KetoSwiss raises $4 million, #SplintInvest wins CHF150k, #ArcoScreen & @ExomotionTech receive CHF100k, @RaytheonTech invests in @H55aEro, and more news https://t.co/dGdnlqxqWC

[KetoSwiss @KetoSwiss]

We are happy to announce the closure of our $4M pre-series A financing round! Many thanks to our new investors: The William K. Warren Foundation, Baszucki Group @DavidBaszucki @janellison, @R42group, @HealthspanCap and @orthomol for your trust and support!
@brainritual

[Basel Area Life Sciences Supercluster @BaselArea]

📰Basel-based startup @KetoSwiss, which our Venture Mentoring supported, has received USD 4 million in a Pre-Series A funding round. KetoSwiss is developing a new therapy to alleviate neurological conditions.

Read more 👇
https://t.co/9zobd6H8ve

[startupticker @startuptickerCH]

Basel-based Biotech @KetoSwiss secures $4 million pre-seed capital to launch its migrane mitigating solution in the US. Multiple investors supported the startup. https://t.co/0sYENSpPFz

[KetoSwiss @KetoSwiss]

Did you know the influence of ketones can outlast their nutritional and metabolic effects? 🕒 Learn more about their power in our new @brainritual blog post!

https://t.co/bjmOeCsvqg

#ketones #metabolism #genetics #biology #health

[Longevity Investors @Longevity_Inv]

Join us for an exciting panel discussion “Supplements guide for healthy aging” at the Longevity Investors Conference in Gstaad on September 28-30. @Sabinije @DrElenaGross @KetoSwiss @AveaLife Apply for your seat here: https://t.co/xxAEYTNWPU #LongevityInvestors

[KetoSwiss @KetoSwiss]

Our @brainritual blog is back! Make sure to check out our newest article on genes-environment interactions in the context of longevity, and the role of Southern Italians in elucidating the interplay 👴🇮🇹🧬
#genetics #longevity #alzheimers #neuroscience
https://t.co/NwZBXUjjTD

[David Weinkove @dweinkove]

“Migraine is as much a metabolic disease as a neurological disease” @DrElenaGross at @longevityleader. She has a company addressing metabolic causes of many conditions. @KetoSwiss